High-stakes lawsuits accusing drugmakers, distributors, and pharmacies of stoking the national opioid scourge have suffered two major recent setbacks, and now it looks like plaintiffs could be headed for strike three. Only this time the problem may be less a controversial legal theory than a freelance Miss Marple on the jury. In Cleveland, the jury…